West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q1 2022 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET

Company Participants

Quintin Lai - VP, IR
Eric Green - President and CEO
Bernard Birkett - CFO

Conference Call Participants

Larry Solow - CJS Securities
Justin Lin - William Blair
Paul Knight - KeyBanc
Jacob Johnson - Stephens
Derik De Bruin - Bank of America
Dave Windley - Jefferies

Operator

Good day and thank you for standing by. Welcome to the Q1 2022 West Pharmaceutical Services Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. Please be advised that today conference call is being recorded. [Operator Instructions]

I would now like to hand the conference over to your speaker for today, Quintin Lai, Vice President of Investor Relations. Please go ahead.

Quintin Lai

Thank you, Didi. Good morning and welcome to West’s first quarter 2022 conference call. We issued our financial results this morning and the release has been posted in the Investors section on the company’s website located at westpharma.com.

This morning, CEO, Eric Green; and CFO, Bernard Birkett will review our financial results, provide an update on our business, and present an update on our financial outlook for the full year 2022.

There is a slide presentation that accompanies today’s call and a copy of that presentation is available on the Investors section of our website. On slide four is our Safe Harbor statement. Statements made by the management on this call and in the accompanying presentation contain forward-looking statements within the meaning of US federal securities law.

These statements are based on our beliefs and assumptions, current expectations, estimates and forecasts. The company’s future results are influenced by many factors beyond the control of the company.

Actual